Versigent (NYSE:VGNT – Get Free Report) was upgraded by analysts at Fox Advisors to a “strong-buy” rating in a research report issued to clients and investors on Tuesday,Zacks.com reports.
Other analysts have also recently issued reports about the stock. Wells Fargo & Company started coverage on shares of Versigent in a research note on Monday. They set an “overweight” rating and a $35.00 price target on the stock. Royal Bank Of Canada began coverage on shares of Versigent in a research note on Tuesday, March 31st. They issued a “sector perform” rating and a $28.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, Versigent currently has a consensus rating of “Buy” and a consensus price target of $31.50.
Read Our Latest Stock Report on Versigent
Versigent Price Performance
Further Reading
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
